NOVOSOM

Novosom is working with its partners to develop unique antisense, DNAi and siRNA based therapeutics with a current focus in inflammation, oncology and liver diseases. Novosom’s Smarticles® liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical or systemic applications. Smarticles are an enabler of systemic treatments and an enhancer of topical treatments. The Company has several active therapeutically-relevant collaborations in oncology and inflammation. Novosom AG main investors include IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH and MBG Mittelständische Beteiligungs-gesellschaft Sachsen Anhalt.

#SimilarOrganizations #More

NOVOSOM

Industry:
Biotechnology Health Care

Founded:
1999-01-01

Address:
Halle, Sachsen-Anhalt, Germany

Country:
Germany

Status:
Active

Contact:
+49 345 55 59 836


Similar Organizations

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

peptinov-logo

Peptinov

Peptinov is a biotech company developing innovative anti-cytokine products.

More informations about "Novosom"

Novosom - Crunchbase Company Profile & Funding

Novosom is working with its partners to develop unique antisense, DNAi and siRNA based therapeutics with a current focus in inflammation, oncology and liver diseases. Novosom’s …See details»

Novosom Company Profile 2024: Valuation, Investors, Acquisition

Novosom was founded in 1999. Where is Novosom headquartered? Novosom is headquartered in Halle, Germany. What is the size of Novosom? Novosom has 18 total employees. What …See details»

novosom AG - LinkedIn

Novosom AG is a biopharmaceutical company with a pioneering, fully charge-reversible liposomal technology for the delivery of DNA based therapeutics. novosom's SMARTICLES® allow the …See details»

Novosom AG - Company Profile and News - Bloomberg Markets

Novosom AG operates as a biopharmaceutical company focused on DNA based therapeutics. The Company researches and develops liposomal technology for the delivery of intracellular …See details»

novosom - Products, Competitors, Financials, Employees, …

Developer of high-end drug delivery solutions for nucleic acids and biologicals. The company develops a technology designed to enable the delivery of antisense and siRNA in vivo, as well …See details»

Novosom AG - VentureRadar

Find out more about Novosom AG, Healthtech and Life Sciences and Life Sciences.See details»

NovaSom - Crunchbase Company Profile & Funding

NovaSom, Inc. is a privately held diagnostic-service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of obstructive sleep apnea (OSA). …See details»

Ercole and Novosom AG announce antisense delivery success

Mar 23, 2004 · Ercole Biotech, Inc., and novosom AG announced the successful completion of the first phase of their research collaboration. The research involves the intracellular targeted …See details»

Novosom - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Novosom is working with its partners to develop unique antisense, DNAi and siRNA.See details»

NovaSom Company Profile - Office Locations, Competitors ... - Craft

NovaSom has integrated their home sleep testing system into a cloud based, collaborative patient management platform for physicians and payers. See insights on NovaSom including office …See details»

ProNAi and Novosom Announce Collaboration to ... - Technology …

Mar 7, 2007 · ProNAi will license Novosom’s SMARTICLES® liposome technology to help advance PNT100 drug candidate toward IND, and to enable delivering nucleotides in vivo to …See details»

Novosom AG Acquires Exclusive License from Isis Pharmaceuticals …

Aug 26, 2008 · Novosom AG today announced that it has acquired an exclusive, worldwide license from Isis Pharmaceuticals to access certain antisense inhibitors targeting CD40 mRNA …See details»

IN BRIEF: BioSerenity to buy NovaSom out of bankruptcy

Sep 23, 2019 · NovaSom Inc, a bankrupt developer of a medical device used at home to record sleep apnea symptoms, said in a filing on Monday it is canceling its planned auction after …See details»

NovaSom Company Profile 2024: Valuation, Funding & Investors

Developer of home-testing services designed to provide continuous patient support. The company's home-testing services provides evaluation of sleep-disordered breathing, which …See details»

Novosom Acquires Exclusive Option for Antisense Inhibitors from …

Apr 11, 2007 · The option will provide the Novosom with a worldwide licence to antisense inhibitors targeting the CD40 membrane protein for all indications.See details»

NovaSom, Inc. Provides Home Sleep Testing Services for …

Feb 17, 2012 · NovaSom, Inc. is the market leader in obstructive sleep apnea (OSA) home testing, with the first FDA-cleared system and more than 10 years of experience in home sleep …See details»

VirtuOx Seeks to Acquire Substantially All Assets of NovaSom

On Aug 2, 2019, NovaSom Inc sought relief from its creditors under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. NovaSom is a …See details»

Novo: Make New

Choose from over 30 locations around the world to hear about people who have been awakened to their identity in Jesus and ability to hear his voice, equipped with tools to reach out to the …See details»

In the community - Novo Nordisk

Through partnerships with healthcare providers and not-for-profit organizations, we help drive research, advocacy and awareness initiatives to improve access to diabetes education, care …See details»

Novo Canada | Make New

Novo is a band of creative missionaries sent to multiply movements of the gospel and mobilize the church for mission around the world.See details»

linkstock.net © 2022. All rights reserved